98%
921
2 minutes
20
Background: Oncoplastic reconstructive surgery as an extension of breast-conserving surgery leads to better aesthetic results, an increase in tumor-free margins, and a reduction in reexcision rates. Oncologic resection is often more extensive than expected, sometimes resulting in the plastic surgeon deviating from the predetermined plan. For optimal planning of the reconstruction, it is mandatory to estimate volume defects after lumpectomy as accurately as possible. The authors aimed to identify preoperative predictors of lumpectomy resection size.
Methods: All consecutive patients diagnosed with invasive breast carcinoma or carcinoma in situ and treated primarily with breast-conserving surgery between 2018 and 2020 at the University Medical Center Utrecht or Alexander Monro Hospital were included. Patient and tumor characteristics were measured. Data were analyzed in a multiple linear regression analysis.
Results: A total of 410 patients (423 cases) were included, with a median age of 58 years (range, 32 to 84 years) and a mean body mass index (BMI) of 25.0 (SD 9.3). The mean maximum radiologic tumor diameter was 18.0 mm (SD 13.2), and the mean maximum lumpectomy diameter was 58.8 mm (SD 19.2). Multiple linear regression analysis found an explained variance of R 2 = 0.60 ( P < 0.00), corrected for operating surgeon. Significant predictors for postoperative lumpectomy size were BMI, breast size, and maximum preoperative radiologic tumor diameter. A predictive tool for lumpectomy size was developed and a web-based application created to facilitate use of the tool in a clinical setting.
Conclusions: Postoperative lumpectomy size can be predicted using BMI, breast size, and radiologic tumor size. This model could be beneficial for breast surgeons in planning reconstructions and preparing and informing their patients more accurately.
Clinical Question/level Of Evidence: Risk, III.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346708 | PMC |
http://dx.doi.org/10.1097/PRS.0000000000011085 | DOI Listing |
Medicine (Baltimore)
September 2025
Department of General Surgery, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
Background: In patients scheduled for breast-conserving surgery (BCS) after neoadjuvant chemotherapy, the primary mass is marked with a metallic clip. A comparative study was conducted to determine the efficacy and safety of tattoo application as an alternative to this invasive procedure.
Methods: Forty patients (clip: 20, tattoo: 20) after neoadjuvant chemotherapy, in the group marked with clips, nonpalpable patients were marked with wire, and BCS was performed; in the tattoo group, BCS was performed with the skin containing the tattoo.
Front Oncol
August 2025
Department of Thyroid and Breast Surgery, The Fourth People's Hospital of Jinan, Jinan, China.
We present the case of a 67-year-old female who developed simultaneous metastases to the ampulla of Vater and the breast. Her medical history is significant for a radical nephrectomy performed twenty-one years prior for renal cell carcinoma (RCC). The patient was referred for evaluation due to the development of progressive jaundice, fatigue, and weight loss.
View Article and Find Full Text PDFJ Appl Clin Med Phys
September 2025
Department of Radiation Oncology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Purpose: This study aimed to comprehensively compare the dosimetric characteristics of three different radiotherapy techniques-hybrid intensity-modulated radiotherapy (hy-IMRT), tangential volumetric-modulated arc therapy (t-VMAT), and continuous volumetric-modulated arc therapy (c-VMAT)-used after breast-conserving surgery for left-sided breast cancer in the target area and organs at risk (OARs) after breast-conserving surgery for left-sided breast cancer. This evaluation aims to provide a solid basis for individualized radiotherapy planning in clinical practice.
Methods: Twenty female patients who underwent breast-conserving surgery for left-sided breast cancer were retrospectively selected.
Breast Care (Basel)
August 2025
Department of Surgical Oncology, University Medical Center, Utrecht, The Netherlands.
Purpose: Positive margins after breast-conserving surgery (BCS) are an important risk factor for local tumor recurrence and the need for re-excision in women with breast cancer. It remains unclear which factors collectively influence positive margins after BCS and whether the outcomes vary among hospitals. This study investigated the occurrence and risk factors of positive margins after BCS in women with breast cancer in two Dutch hospitals.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, No.1, Youyi Road, Yuzhong District, Chongqing, 400016, China.
Cohort studies have suggested that breast-conserving therapy (BCT) offers better survival outcomes compared to mastectomy in patients with early breast cancer (BC). However, survival comparisons between BCT and mastectomy with breast reconstruction (Mastectomy + BR) are lacking. To investigate this, we conducted a cohort study using data from the SEER database.
View Article and Find Full Text PDF